 CAMBRIDGE, Mass.--BUSINESS WIRE--- SAGE Sage--Sage Therapeutics, Inc. NASDAQ:SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the BMO 2020 Growth ESG Conference on Wednesday, December 9, 2020 at 3:00 p.m. ET. A live webcast of the presentation can be accessed on the investor page of Sages website at investor.sagerx.com. A replay of 